Friday, March 29, 2013

Cell Therapeutics Gets $15M In Debt Funding

Seattle-based Cell Therapeutics said Thursday that it has received $15M in a senior secured term loan. The funding came from Hercules Technology Growth Capital. Terms of that loan were not announced. Cell Therapeutics said it would use the loan to advance its Phase 3 clinical development programs.